Dr. Ben Sessa, M.D is a psychiatrist and chief science officer of Awakn Life Sciences, a publicly traded (NEO: AWKN) (OTCQB: AWKNF) biotechnology company with clinical operations; researching, developing, and delivering psychedelic medicine to treat addiction better. In this podcast, we focus on childhood trauma and new emerging evidence on psychedelic medicines.